Cargando…
Higher serum interleukin‐12 levels are associated with the pathophysiology of major depressive disorder: A case‐control study results
BACKGROUND AND AIMS: Major depressive disorder (MDD) is the fourth biggest health‐related concern that dramatically impacts individuals' mental and physical health. Alteration of serum proinflammatory cytokine levels may take part in the development and progression of MDD. We aimed to explore a...
Autores principales: | Nahar, Zabun, Sal‐Sabil, Nisat, Sohan, Md., Qusar, MMA Shalahuddin, Islam, Md. Rabiul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9789678/ https://www.ncbi.nlm.nih.gov/pubmed/36582626 http://dx.doi.org/10.1002/hsr2.1005 |
Ejemplares similares
-
Evaluation of serum interleukin‐1 receptor antagonist levels in major depressive disorder: A case‐control study
por: Nahar, Zabun, et al.
Publicado: (2023) -
Increased serum resistin but not G-CSF levels are associated in the pathophysiology of major depressive disorder: Findings from a case-control study
por: Rahman, Smaranika, et al.
Publicado: (2022) -
Higher serum nerve growth factor levels are associated with major
depressive disorder pathophysiology: a case–control study
por: Salsabil, Lubaba, et al.
Publicado: (2023) -
Altered IL-3 and lipocalin-2 levels are associated with the pathophysiology of major depressive disorder: a case-control study
por: Akter, Sarmin, et al.
Publicado: (2023) -
Association of reduced serum EGF and leptin levels with the pathophysiology of major depressive disorder: A case-control study
por: Sohan, Md., et al.
Publicado: (2023)